Redcare Pharmacy earnings update
Redcare Pharmacy (XTRA:RDC) just posted nine month figures to September 30, 2026, with sales of €2,549.7 million versus €2,145.7 million a year earlier, and a reduced net loss of €5 million compared with €8.7 million.
Redcare Pharmacy shares have picked up momentum in recent months, with a 30 day share price return of 16.2% and a 90 day gain of 22.39% at a latest share price of €79.25, even though the 3 year total shareholder return is still down 25.09% and the 5 year total shareholder return is down 45.38%.
Scan Redcare Pharmacy's momentum against a curated 191 high quality undervalued stocks that combines solid cash generation with resilient balance sheets.
Redcare Pharmacy now combines higher sales and a slimmer loss with a sharply stronger share price. The real tension is simple: are you paying up for genuine business strength or just recent momentum, as the valuation section shows?
Most Popular Narrative: 10.8% Undervalued
Against a last close of €79.25, the most followed Redcare Pharmacy thesis puts fair value at €88.80. The current price still trails that narrative benchmark while earnings remain in loss making territory.
Scaling of logistics investments such as the new Pilsen center and the Sevenum automation project, which target up to 70% lower labor cost per order and capacity increases from 2027, is set to improve fulfillment efficiency and support adjusted EBITDA margin and net profit.
See why 11 investors see Redcare Pharmacy as 11% undervalued.
Result: Fair Value of €88.80 (UNDERVALUED)
Still, Redcare Pharmacy faces real pressure if German or EU prescription rules shift unfavourably, or if non-prescription rivals keep squeezing pricing and marketing efficiency.
Find out about the key risks to this Redcare Pharmacy narrative.
Another View: What Redcare Pharmacy’s Sales Multiple Signals
That €88.80 fair value comes from earnings based assumptions. On a simple sales multiple, Redcare Pharmacy looks less generous. The shares trade on a P/S of 0.5x, compared with 0.4x for the European Consumer Retailing group and a fair ratio of 0.2x, which points to valuation risk if sentiment cools.
If you prefer to anchor your thinking on market based ratios rather than cash flow projections, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed views on whether Redcare Pharmacy is recovering or already fully priced. Act while sentiment is fresh and weigh both sides using the 2 key rewards and 1 important warning sign.
Looking for more Redcare Pharmacy style ideas?
If you stop at Redcare Pharmacy, you miss a wider set of potential opportunities. Use the Simply Wall Street Screener to scan other shares with clear data and consistent methodology.
- Target resilient balance sheets and steady fundamentals by running a focused search through the list of solid balance sheet and fundamentals (206 results).
- Hunt for quality at a discount by comparing valuations with the 608 high quality undiscovered gems.
- Dial back risk while staying invested by filtering for stability using the 229 resilient stocks with low risk scores.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com